← Open Payments lookup

SHAOJIE HAN: Open Payments

NPI 1073811832 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,451 in 173 payments from 16 companies in 2025. Trend: 2023 $2,676 · 2024 $2,685 · 2025 $3,451

Food & beverage: $3,449Education: $2
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$552
Neurocrine BioSciences, Inc.14$387
Otsuka America Pharmaceutical, Inc.22$379
Alkermes, Inc.15$320
Corium, LLC20$302
Lundbeck LLC12$278
ABBVIE INC.14$217
Takeda Pharmaceuticals U.S.A., Inc.10$211
Teva Pharmaceuticals USA, Inc.13$185
E.R. Squibb & Sons, L.L.C.7$178

Products named: CAPLYTA, REXULTI, INGREZZA, ARISTADA, Azstarys, VRAYLAR, TRINTELLIX, COBENFY.

Industry payments across TX — which companies pay providers there.